by Chris Lee | May 6, 2016 | Stocks Analysis [Simple], Top Articles
One of the first stock that I bought was called iShares Nasdaq Biotechnology ETF (NASDAQ: IBB). I bought it on 5th February 2015 at $310.51 and sold it on 13th July 2015 at $380, netting a cool 21.39%. I like biotechnology stock and so far I have had good experience... ![[Edited] Here Is Why I Would Not Buy ComfortDelGro (SGX: C52.SI) Stock…](https://theartofvalueinvesting.com/wp-content/uploads/2016/03/Comfort-Delgro-Logo.jpg)
by Chris Lee | Mar 7, 2016 | Investing, Stocks Analysis [Simple]
How I Decided To Take A Look At This Company I already have my Indonesian Driving License from around 4 years back and I wanted to convert it to Singapore Driving License. Little did I know that It is not that simple- One of the criteria for conversion is that I have... 
by Chris Lee | Feb 1, 2016 | Investing, My Stocks Updates, Stocks Analysis [Simple], Top Articles
About Keppel Corporation Keppel Corporation (SGX: BN4) is operating and emphasized as a multi-business company that derives its revenue from four sources. The four sources of income are from Offshore and marine, Property, Infrastructure and investments starting from... 
by Chris Lee | Jan 27, 2016 | Investing, My Stocks Updates, Stocks Analysis [Simple]
KERX is one the top holdings of my portfolio to which I categorized it as a growth stock – which means there is a potential for it to grow multi-fold in terms of the stock price. I first talked about KERX in my earlier article and it gives a good summary of the... 
by Chris Lee | Jan 22, 2016 | Investing, My Stocks Updates, Stocks Analysis [Simple]
Keppel DC REIT (AGX: AJBU) is a Singapore-based real estate investment trust (REIT), established with the main investment strategy of investing in a portfolio of income-producing real estate assets which are used primarily for data centre purposes, with an initial... 
by Chris Lee | Dec 24, 2015 | Investing, My Stocks Updates, Stocks Analysis [Simple]
Keryx Biopharmaceuticals Inc (NASDAQ: KERX) is essentially a bio-pharmaceutical company focused on the research, development and commercialization of pharmaceutical products geared towards patients with kidney disease and their healthcare providers. High volatility c...